BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
65.29
-0.32 (-0.49%)
At close: Aug 27, 2026, 4:00 PM EDT
64.00
-1.29 (-1.98%)
After-hours: Aug 27, 2026, 5:28 PM EDT
BioMarin Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 874.01 | 1,312 | 942.84 | 755.13 | 724.53 | 587.28 |
Short-Term Investments | - | 248.93 | 194.86 | 318.68 | 567.01 | 426.6 |
Cash & Short-Term Investments | 874.01 | 1,561 | 1,138 | 1,074 | 1,292 | 1,014 |
Cash Growth | -38.97% | 37.17% | 5.95% | -16.86% | 27.39% | -4.83% |
Receivables | 1,061 | 908.21 | 660.54 | 633.7 | 461.32 | 373.4 |
Inventory | 1,783 | 1,299 | 1,233 | 1,107 | 894.08 | 776.67 |
Other Current Assets | 254.05 | 185.78 | 201.53 | 141.39 | 104.52 | 110.44 |
Total Current Assets | 3,972 | 3,953 | 3,232 | 2,956 | 2,751 | 2,274 |
Property, Plant & Equipment | 989.99 | 991.8 | 1,077 | 1,112 | 1,114 | 1,082 |
Long-Term Investments | - | 492.24 | 521.24 | 622.44 | 370.34 | 524.29 |
Goodwill | 655.75 | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 |
Other Intangible Assets | 4,879 | 310.84 | 320.98 | 325.3 | 338.57 | 388.65 |
Long-Term Deferred Tax Assets | 888.58 | 1,509 | 1,489 | 1,546 | 1,505 | 1,450 |
Other Long-Term Assets | 338.14 | 140.76 | 151.94 | 83.56 | 98.78 | 89.2 |
Total Assets | 11,723 | 7,594 | 6,989 | 6,842 | 6,375 | 6,005 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 406.98 | 312.77 | 235.4 | 315.51 | 231.24 | 199.68 |
Accrued Expenses | 526.66 | 394.32 | 331.27 | 311.55 | 293.53 | 267.65 |
Current Portion of Long-Term Debt | 658.2 | - | - | 493.88 | - | - |
Current Portion of Leases | 16.06 | 8.69 | 7.57 | 8.78 | 10.38 | 10.46 |
Current Income Taxes Payable | 9.14 | 3.67 | 12.57 | 2.65 | 16.21 | 1.21 |
Current Unearned Revenue | - | - | - | 4.62 | 0.71 | 6.96 |
Other Current Liabilities | 46.96 | 39.6 | 20.17 | 40.04 | 36.81 | 60.54 |
Total Current Liabilities | 1,664 | 759.03 | 606.99 | 1,177 | 588.88 | 546.5 |
Long-Term Debt | 3,528 | 597.18 | 595.14 | 593.1 | 1,083 | 1,079 |
Long-Term Leases | - | 37.01 | 31.26 | 38.12 | 26.51 | 33.84 |
Other Long-Term Liabilities | 209.82 | 113.8 | 97.57 | 81.81 | 73.5 | 79.69 |
Total Liabilities | 5,402 | 1,507 | 1,331 | 1,890 | 1,772 | 1,739 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 |
Additional Paid-In Capital | 6,037 | 5,957 | 5,802 | 5,612 | 5,405 | 5,192 |
Retained Earnings | 304.5 | 154.21 | -194.7 | -621.55 | -789.2 | -930.76 |
Comprehensive Income & Other | -20.02 | -23.98 | 50.43 | -38.65 | -12.73 | 4.74 |
Shareholders' Equity | 6,322 | 6,087 | 5,658 | 4,952 | 4,603 | 4,266 |
Total Liabilities & Equity | 11,723 | 7,594 | 6,989 | 6,842 | 6,375 | 6,005 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,202 | 642.87 | 633.97 | 1,134 | 1,120 | 1,123 |
Net Cash (Debt) | -3,328 | 917.74 | 503.74 | -60.07 | 171.63 | -109.51 |
Net Cash Growth | - | 82.19% | - | - | - | - |
Net Cash Per Share | -16.97 | 4.65 | 2.56 | -0.31 | 0.91 | -0.60 |
Filing Date Shares Outstanding | 193.57 | 192.32 | 190.78 | 188.68 | 186.53 | 184.03 |
Total Common Shares Outstanding | 193.54 | 192.3 | 190.76 | 188.6 | 186.25 | 183.91 |
Working Capital | 2,308 | 3,194 | 2,625 | 1,779 | 2,163 | 1,728 |
Book Value Per Share | 32.66 | 31.65 | 29.66 | 26.25 | 24.71 | 23.19 |
Tangible Book Value | 786.58 | 5,580 | 5,141 | 4,430 | 4,068 | 3,681 |
Tangible Book Value Per Share | 4.06 | 29.02 | 26.95 | 23.49 | 21.84 | 20.01 |
Land | - | 90.78 | 90.78 | 90.78 | 90.79 | 90.42 |
Buildings | - | 910.71 | 892.48 | 860.81 | 819.1 | 774.92 |
Machinery | - | 818.81 | 789.5 | 796.61 | 736.25 | 688.54 |
Construction In Progress | - | 134.91 | 90.27 | 100.01 | 143.38 | 136.74 |
Leasehold Improvements | - | 44.04 | 44.37 | 58.23 | 59.53 | 55.28 |